Related Experiment Video

Updated: Dec 26, 2025

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.6K

Influence of overweight and obesity on acute appendicitis in children. A cohort study

C Delgado-Miguel1, A J Muñoz-Serrano1, S Barrena Delfa1

  • 1Pediatric Surgery Department. Hospital Universitario La Paz. Madrid (Spain).

Cirugia Pediatrica : Organo Oficial De La Sociedad Espanola De Cirugia Pediatrica
|March 14, 2020
PubMed

Insights

Overweight and obese children with appendicitis face increased risks of surgical wound infections and dehiscence. This study highlights the importance of considering body mass index (BMI) in pediatric appendicitis outcomes.

Area of Science:

  • Pediatric Surgery
  • Obesity Research
  • Clinical Outcomes

Background:

  • Postsurgical complications in acute appendicitis are linked to overweight and obesity in adults.
  • Limited research exists on these effects in pediatric populations.
  • Investigating BMI's impact on pediatric appendicitis is crucial.

Purpose of the Study:

  • To analyze the influence of overweight and obesity on the postoperative course of acute appendicitis in children.
  • To compare complication rates between normal weight and overweight/obese pediatric patients.

Main Methods:

  • A prospective cohort study included 403 pediatric patients undergoing appendicitis surgery.
  • Patients were categorized into overweight-obese and normal weight cohorts based on BMI.
  • Outcomes assessed included operating time, hospital stay, and early postoperative complications.

Main Results:

  • Overweight-obese children experienced longer operating times compared to normal weight children.
  • The overweight-obese group had significantly higher rates of surgical wound infection and wound dehiscence.
  • No significant differences were found in intra-abdominal abscess rates or hospital stay.

Conclusions:

  • Overweight and obese children with appendicitis exhibit a greater risk of developing surgical wound infections and dehiscence.
  • These findings underscore the need for tailored perioperative management in pediatric appendicitis patients with higher BMI.
Abstract

Keywords:
AppendicitisBody mass indexPediatric obesityPostoperative complicationsSurgical wound infection

More Related Videos

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study03:05

Influence of Emotional Factors on the Efficacy of Acupuncture Treatment for Overweight Complicated with Hyperlipidemia: A Retrospective Cohort Study

Published on: November 21, 2025

370
Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment05:18

Acupoint Catgut Embedding Therapy for Abdominal Obesity Treatment

Published on: November 22, 2024

1.2K

Related Concept Videos

Appendicitis-I: Introduction01:22

Appendicitis-I: Introduction

The appendix, a small, narrow, blind tube extending from the inferior part of the cecum, is widely regarded as a vestigial organ, having lost much of its original function through evolution. Despite its diminished role, the appendix can become inflamed, a condition known as appendicitis.
Etiology: Appendicitis can arise from various causes, primarily rooted in the obstruction of the appendix lumen. Factors contributing to this obstruction include fecal accumulation, lymphoid hyperplasia and, in...
1.9K
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
399
Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
189
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
166
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion01:20

Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion

Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
123